These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 31137841)

  • 21. Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system.
    Xie FY; Xu WH; Yin C; Zhang GQ; Zhong YQ; Gao J
    World J Gastrointest Oncol; 2016 Oct; 8(10):735-744. PubMed ID: 27795813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer Stem Cell for Tumor Therapy.
    Huang B; Yan X; Li Y
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer Stem Cell Metabolism and Potential Therapeutic Targets.
    Snyder V; Reed-Newman TC; Arnold L; Thomas SM; Anant S
    Front Oncol; 2018; 8():203. PubMed ID: 29922594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy.
    Zheng X; Yu C; Xu M
    Front Oncol; 2021; 11():678333. PubMed ID: 34262865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PGE
    Lin MC; Chen SY; He PL; Herschman H; Li HJ
    Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can lung cancer stem cells be targeted for therapies?
    Wu X; Chen H; Wang X
    Cancer Treat Rev; 2012 Oct; 38(6):580-8. PubMed ID: 22436486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting Cancer Stem Cells: Promises and Challenges.
    Kuhlmann JD; Hein L; Kurth I; Wimberger P; Dubrovska A
    Anticancer Agents Med Chem; 2016; 16(1):38-58. PubMed ID: 26179271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting cancer stem cells in drug discovery: Current state and future perspectives.
    Du FY; Zhou QF; Sun WJ; Chen GL
    World J Stem Cells; 2019 Jul; 11(7):398-420. PubMed ID: 31396368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer Stem Cell and Gastrointestinal Cancer: Current Status, Targeted Therapy and Future Implications.
    Ahmad R; Dhawan P; Singh AB
    Biochem Pharmacol (Los Angel); 2016; 5(2):. PubMed ID: 31656694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Cancer Stem Cell in Hepatocellular Carcinoma.
    Schulte LA; López-Gil JC; Sainz B; Hermann PC
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32183251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.
    De Angelis ML; Zeuner A; Policicchio E; Russo G; Bruselles A; Signore M; Vitale S; De Luca G; Pilozzi E; Boe A; Stassi G; Ricci-Vitiani L; Amoreo CA; Pagliuca A; Francescangeli F; Tartaglia M; De Maria R; Baiocchi M
    Stem Cells Transl Med; 2016 Apr; 5(4):511-23. PubMed ID: 26956206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Clinical Impact of Cancer Stem Cells.
    Lathia J; Liu H; Matei D
    Oncologist; 2020 Feb; 25(2):123-131. PubMed ID: 32043793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer.
    Hu Z; Xu J; Cheng J; McMichael E; Yu L; Carson WE
    Oncotarget; 2017 Jan; 8(1):1481-1494. PubMed ID: 27903969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapies targeting cancer stem cells: Current trends and future challenges.
    Dragu DL; Necula LG; Bleotu C; Diaconu CC; Chivu-Economescu M
    World J Stem Cells; 2015 Oct; 7(9):1185-201. PubMed ID: 26516409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bmi-1: A master regulator of head and neck cancer stemness.
    Herzog AE; Somayaji R; Nör JE
    Front Oral Health; 2023; 4():1080255. PubMed ID: 36726797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An alginate-based platform for cancer stem cell research.
    Qiao SP; Zhao YF; Li CF; Yin YB; Meng QY; Lin FH; Liu Y; Hou XL; Guo K; Chen XB; Tian WM
    Acta Biomater; 2016 Jun; 37():83-92. PubMed ID: 27109764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic targeting of the crosstalk between cancer-associated fibroblasts and cancer stem cells.
    Huang TX; Guan XY; Fu L
    Am J Cancer Res; 2019; 9(9):1889-1904. PubMed ID: 31598393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
    Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
    BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Cancer Stem Cell Markers or Pathways: A Potential Therapeutic Strategy for Oral Cancer Treatment.
    Lee JW; Lee HY
    Int J Stem Cells; 2021 Nov; 14(4):386-399. PubMed ID: 34711702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.